XBiotech Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by XBiotech Inc. on June 23, 2023, regarding the results of its annual meeting of stockholders held on the same date. The company is incorporated in British Columbia, Canada, with principal executive offices in Austin, Texas.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted in accordance with the Board of Directors' recommendations on two proposals:
- Proposal #1: Election of Directors Five nominees were elected to the Board of Directors. The vote counts were as follows:
- John Simard: 8,804,043 For, 99,883 Abstain, 2,132,811 Broker Non-Votes
- Jan-Paul Waldin: 7,206,409 For, 1,697,517 Abstain, 2,132,811 Broker Non-Votes
- W. Thorpe McKenzie: 8,360,436 For, 543,490 Abstain, 2,132,811 Broker Non-Votes
- Donald MacAdam: 8,689,522 For, 214,404 Abstain, 2,132,811 Broker Non-Votes
- Peter Libby: 8,801,167 For, 102,759 Abstain, 2,132,811 Broker Non-Votes
- Proposal #2: Ratification of Auditors Stockholders ratified the selection of Whitley Penn LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023. The vote counts were: 10,983,720 For, 51,402 Against, 1,615 Abstain, and 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that Whitley Penn LLP is the appointed auditor for the fiscal year ending December 31, 2023.
- Verification of the new Board of Directors composition following the election of the five nominees.
- Review of the significant number of broker non-votes (2,132,811) recorded for the director elections.